0001144204-17-002791.txt : 20170118
0001144204-17-002791.hdr.sgml : 20170118
20170118193440
ACCESSION NUMBER: 0001144204-17-002791
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170113
FILED AS OF DATE: 20170118
DATE AS OF CHANGE: 20170118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taurus4757 GmbH
CENTRAL INDEX KEY: 0001603397
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 17534621
BUSINESS ADDRESS:
STREET 1: WISSMANNSTRASSE 15
CITY: ZURICH
STATE: V8
ZIP: CH 8057
BUSINESS PHONE: 414 43620406
MAIL ADDRESS:
STREET 1: WISSMANNSTRASSE 15
CITY: ZURICH
STATE: V8
ZIP: CH 8057
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS
CENTRAL INDEX KEY: 0001273547
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 17534622
4
1
v456505_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-01-13
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001273547
GIRSCHWEILER THOMAS
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
0
1
0
0001603397
Taurus4757 GmbH
WISSMANNSTRASSE 15
ZURICH
V8
CH 8057
SWITZERLAND
0
0
1
0
Common Stock
2017-01-13
4
A
0
3106
A
2719197
I
By Taurus4757 GmbH
The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter.
/s/ Thomas Girschweiler
2017-01-18
/s/ Roderick de Greef, as attorney-in-fact for Thomas Girschweiler and Taurus4757 GmbH
2017-01-18